What to expect when you take Incivek and have Talipes?

Do you take Incivek and have Talipes? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 16, 2018

9,456 reports have been studied.


Females aged 50 to 59 :

3,985 related reports were analyzed:

Most common symptoms:

Anaemia
  • 21.25% for females aged 50 (±5) who take Incivek
Anorectal discomfort
  • 8.18% for females aged 50 (±5) who take Incivek
Appetite - decreased
  • 8.43% for females aged 50 (±5) who take Incivek
Chills
  • 5.07% for females aged 50 (±5) who take Incivek
Diarrhea
  • 10.36% for females aged 50 (±5) who take Incivek
Dizziness
  • 6.5% for females aged 50 (±5) who take Incivek
Dyspnea
  • 7.75% for females aged 50 (±5) who take Incivek
Fatigue
  • 22.08% for females aged 50 (±5) who take Incivek
Fever
  • 7.13% for females aged 50 (±5) who take Incivek
Headache
  • 9.54% for females aged 50 (±5) who take Incivek
Influenza like illness
  • 5.35% for females aged 50 (±5) who take Incivek
Itching
  • 11.39% for females aged 50 (±5) who take Incivek
Nausea
  • 22.03% for females aged 50 (±5) who take Incivek
Nausea and vomiting
  • 11.57% for females aged 50 (±5) who take Incivek
Pain
  • 5.07% for females aged 50 (±5) who take Incivek
Rashes
  • 19.87% for females aged 50 (±5) who take Incivek
Thrombocytopenia
  • 5.97% for females aged 50 (±5) who take Incivek
Weakness
  • 7.88% for females aged 50 (±5) who take Incivek
White blood cell count decreased
  • 6.88% for females aged 50 (±5) who take Incivek

Most common co-existing conditions:

  • n/a
back to top

Males aged 50 to 59 :

5,471 related reports were analyzed:

Most common symptoms:

Anaemia
  • 14.9% for males aged 50 (±5) who take Incivek
Anorectal discomfort
  • 9.1% for males aged 50 (±5) who take Incivek
Appetite - decreased
  • 6.34% for males aged 50 (±5) who take Incivek
Diarrhea
  • 9.29% for males aged 50 (±5) who take Incivek
Dizziness
  • 5.59% for males aged 50 (±5) who take Incivek
Dyspnea
  • 6.8% for males aged 50 (±5) who take Incivek
Fatigue
  • 22.43% for males aged 50 (±5) who take Incivek
Fever
  • 6.27% for males aged 50 (±5) who take Incivek
Haemorrhoids
  • 5.12% for males aged 50 (±5) who take Incivek
Headache
  • 8.68% for males aged 50 (±5) who take Incivek
Influenza like illness
  • 7.0% for males aged 50 (±5) who take Incivek
Insomnia
  • 6.2% for males aged 50 (±5) who take Incivek
Itching
  • 12.78% for males aged 50 (±5) who take Incivek
Nausea
  • 15.24% for males aged 50 (±5) who take Incivek
Nausea and vomiting
  • 5.72% for males aged 50 (±5) who take Incivek
Rashes
  • 20.05% for males aged 50 (±5) who take Incivek
Thrombocytopenia
  • 5.32% for males aged 50 (±5) who take Incivek
Weakness
  • 6.0% for males aged 50 (±5) who take Incivek
White blood cell count decreased
  • 5.61% for males aged 50 (±5) who take Incivek

Most common co-existing conditions:

  • n/a
back to top

Do you take Incivek and have Talipes:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

incivek

Incivek has active ingredients of telaprevir. It is often used in hepatitis c. (latest outcomes from Incivek 15,507 users)

talipes

Talipes has been reported by people with depression, stress and anxiety, drug exposure during pregnancy, epilepsy, hiv infection (latest reports from 2,944 Talipes patients).

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.